BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 17627416)

  • 1. The alpha-fetoprotein-derived growth inhibitory peptide 8-mer fragment: review of a novel anticancer agent.
    Mizejewski GJ
    Cancer Biother Radiopharm; 2007 Feb; 22(1):73-98. PubMed ID: 17627416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-fetoprotein growth inhibitory peptides: potential leads for cancer therapeutics.
    Mizejewski GJ; MacColl R
    Mol Cancer Ther; 2003 Nov; 2(11):1243-55. PubMed ID: 14617798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of Growth Inhibitory Peptide as a biotherapeutic agent for tumor growth, adhesion, and metastasis.
    Muehlemann M; Miller KD; Dauphinee M; Mizejewski GJ
    Cancer Metastasis Rev; 2005 Sep; 24(3):441-67. PubMed ID: 16258731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survey of functional activities of alpha-fetoprotein derived growth inhibitory peptides: review and prospects.
    Mizejewskia GJ; Butterstein G
    Curr Protein Pept Sci; 2006 Feb; 7(1):73-100. PubMed ID: 16472170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review and proposed action of alpha-fetoprotein growth inhibitory peptides as estrogen and cytoskeleton-associated factors.
    Mizejewski G; Smith G; Butterstein G
    Cell Biol Int; 2004; 28(12):913-33. PubMed ID: 15566961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update of alpha fetoprotein growth-inhibitory peptides as biotherapeutic agents for tumor growth and metastasis.
    Mizejewski GJ; Muehlemann M; Dauphinee M
    Chemotherapy; 2006; 52(2):83-90. PubMed ID: 16498241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted delivery of anti-cancer growth inhibitory peptides derived from human alpha-fetoprotein: review of an International Multi-Center Collaborative Study.
    Mizejewski GJ; Mirowski M; Garnuszek P; Maurin M; Cohen BD; Poiesz BJ; Posypanova GA; Makarov VA; Severin ES; Severin SE
    J Drug Target; 2010 Sep; 18(8):575-88. PubMed ID: 20151941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticancer versus antigrowth activities of three analogs of the growth-inhibitory peptide: relevance to physicochemical properties.
    Mizejewski GJ; Eisele L; Maccoll R
    Anticancer Res; 2006; 26(4B):3071-6. PubMed ID: 16886636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic peptide derived from alpha-fetoprotein inhibits growth of human breast cancer: investigation of the pharmacophore and synthesis optimization.
    DeFreest LA; Mesfin FB; Joseph L; McLeod DJ; Stallmer A; Reddy S; Balulad SS; Jacobson HI; Andersen TT; Bennett JA
    J Pept Res; 2004 May; 63(5):409-19. PubMed ID: 15140158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-fetoprotein-derived antiestrotrophic octapeptide.
    Mesfin FB; Bennett JA; Jacobson HI; Zhu S; Andersen TT
    Biochim Biophys Acta; 2000 Apr; 1501(1):33-43. PubMed ID: 10727847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiestrogenic and anticancer activities of peptides derived from the active site of alpha-fetoprotein.
    Joseph LC; Bennett JA; Kirschner KN; Shields GC; Hughes J; Lostritto N; Jacobson HI; Andersen TT
    J Pept Sci; 2009 Apr; 15(4):319-25. PubMed ID: 19189271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The alpha-fetoprotein third domain receptor binding fragment: in search of scavenger and associated receptor targets.
    Mizejewski GJ
    J Drug Target; 2015; 23(6):538-51. PubMed ID: 25766080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of Cancer Growth Suppression of Alpha-Fetoprotein Derived Growth Inhibitory Peptides (GIP): Comparison of GIP-34 versus GIP-8 (AFPep). Updates and Prospects.
    Mizejewski GJ
    Cancers (Basel); 2011 Jun; 3(2):2709-33. PubMed ID: 24212829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of an active site peptide analog of α-fetoprotein that prevents breast cancer.
    Jacobson HI; Andersen TT; Bennett JA
    Cancer Prev Res (Phila); 2014 Jun; 7(6):565-73. PubMed ID: 24706695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of N-methyl-N-nitrosourea-induced breast cancer by alpha-fetoprotein (AFP)-derived peptide, a peptide derived from the active site of AFP.
    Parikh RR; Gildener-Leapman N; Narendran A; Lin HY; Lemanski N; Bennett JA; Jacobson HI; Andersen TT
    Clin Cancer Res; 2005 Dec; 11(23):8512-20. PubMed ID: 16322315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and structural and functional characterization of two stable peptic fragments of human alpha-fetoprotein.
    Dudich I; Tokhtamysheva N; Semenkova L; Dudich E; Hellman J; Korpela T
    Biochemistry; 1999 Aug; 38(32):10406-14. PubMed ID: 10441135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-fetoprotein derived from a human hepatoma prevents growth of estrogen-dependent human breast cancer xenografts.
    Bennett JA; Zhu S; Pagano-Mirarchi A; Kellom TA; Jacobson HI
    Clin Cancer Res; 1998 Nov; 4(11):2877-84. PubMed ID: 9829755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural analysis of α-fetoprotein (AFP)-like peptides with anti-breast-cancer properties.
    Temelso B; Alser KA; Gauthier A; Palmer AK; Shields GC
    J Phys Chem B; 2014 May; 118(17):4514-26. PubMed ID: 24702603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of human T-cell responses to an HLA-A2.1-restricted peptide epitope derived from alpha-fetoprotein.
    Butterfield LH; Koh A; Meng W; Vollmer CM; Ribas A; Dissette V; Lee E; Glaspy JA; McBride WH; Economou JS
    Cancer Res; 1999 Jul; 59(13):3134-42. PubMed ID: 10397256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological role of alpha-fetoprotein in cancer: prospects for anticancer therapy.
    Mizejewski GJ
    Expert Rev Anticancer Ther; 2002 Dec; 2(6):709-35. PubMed ID: 12503217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.